You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Aminoacetic Acid 1.5% In Plastic Container, and when can generic versions of Aminoacetic Acid 1.5% In Plastic Container launch?

Aminoacetic Acid 1.5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER is glycine. There are thirty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glycine profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER?
  • What are the global sales for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER?
Summary for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
Drug patent expirations by year for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 017865-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Aminoacetic Acid (0.15%) in Plastic Containers

Last updated: February 21, 2026

What is the Current Market Size and Key Growth Drivers?

Aminoacetic acid, commonly known as glycine, is used primarily in pharmaceutical and nutritional products. The global market for aminoacetic acid is driven by increasing demand for nutritional supplements, pharmaceuticals, and cosmetic applications. The aminoacetic acid segment in plastic containers, particularly at a concentration of 1.5%, is a niche but growing area within the larger amino acid market.

As of 2023, the global amino acids market size is valued at approximately USD 4.3 billion, with an annual growth rate (CAGR) of around 8%. Glycine accounts for approximately 12% of total amino acids consumed, translating to an estimated USD 517 million market.

The demand for compounds like aminoacetic acid in plastic containers has increased due to their stability, ease of handling, and cost-efficiency in packaging. The pharmaceutical applications, including formulations for neurological disorders and as a supplement, contribute to steady growth.

How Is the Market Structured?

Production and Supply Chain

  • Major Producers: China, the United States, India, Japan.
  • Raw Materials: Derived mainly from acetic acid and ammonia through chemical synthesis.
  • Manufacturing Focus: Cost-effective synthesis, high purity standards, and environmental compliance.

Distribution Channels

  • Pharmaceutical companies: Use for injectable and oral formulations.
  • Dietary supplement brands: Incorporate glycine as an additive.
  • Cosmetics: Use in formulations for skin and hair products.

Key Regional Markets

Region Market Share (2023) CAGR (2023–2028) Specific Factors
Asia-Pacific 45% 9% Cost advantages, expanding pharmaceutical sector
North America 25% 7% Regulatory stability, high healthcare spending
Europe 20% 6% Focus on high-quality formulations
Rest of World 10% 8% Emerging markets, local manufacturing capacity

Regulatory Landscape

  • Strict quality and safety standards for pharmaceuticals.
  • FDA and EMA approvals influence market entry.
  • Increasing regulatory focus on sustainable packaging.

What Are the Financial Projections?

Pricing Trends

  • Bulk pharmaceutical grade aminoacetic acid averages USD 5–8 per kilogram.
  • Packaging in plastic containers adds USD 0.2–0.5 per unit.
  • Prices have remained stable with slight inflation (~2%) driven by raw material costs.

Revenue Projections

  • The niche market for 1.5% aminoacetic acid in plastic containers is estimated to grow from USD 150 million in 2023 to USD 200 million by 2028.
  • CAGR of approximately 6% over that period, considering product innovations and expanding applications.
  • The pharmaceutical segment contributes the largest share (around 70%) to revenues, followed by dietary supplements (20%) and cosmetics (10%).

Investment Considerations

  • Capital expenditures for new production lines are between USD 10–20 million, primarily in Asia-Pacific.
  • Mean EBITDA margins are around 15–20%, with premium products and high-volume sales enabling higher margins.
  • Cost competitiveness rooted in raw material expenses influences profitability.

What Are the Competitive Dynamics?

  • Top firms include Ajinomoto, Evonik, and Chow Sang Sang.
  • New entrants face high regulatory hurdles but benefit from lower manufacturing costs in emerging markets.
  • R&D focuses on increasing purity, improving bioavailability, and developing novel formulations.

Market Challenges and Risks

  • Volatility in raw material costs, notably acetic acid and ammonia.
  • Regulatory changes impacting manufacturing standards and export/import policies.
  • Competition from alternative ingredients and synthetic substitutes.

Strategic Opportunities

  • Expanding into new pharmaceutical indications, such as neuroprotective therapies.
  • Developing eco-friendly, biodegradable packaging solutions.
  • Engaging in strategic mergers and acquisitions to enhance manufacturing capacity and geographical coverage.

Key Takeaways

  • Growth driven by pharmaceutical and nutritional sectors.
  • Asia-Pacific dominates the market but faces increasing competition.
  • Stable pricing with potential for margin expansion through product innovation.
  • Regulatory compliance remains central to sustaining market access.

FAQs

  1. What is aminoacetic acid used for in pharmaceuticals?
    It functions as an active ingredient in formulations targeting neurological conditions and as a nutritional supplement.

  2. How does packaging influence the market?
    Plastic containers provide cost-effective and stable packaging, supporting widespread use and distribution.

  3. What factors impact pricing stability?
    Raw material prices, regulatory standards, and supply chain disruptions.

  4. Which regions hold the highest growth potential?
    Asia-Pacific exhibits the highest growth rate due to expanding pharmaceutical manufacturing and lower production costs.

  5. What advancements could impact future market volume?
    Innovations in synthesis, bioavailability, and biodegradable packaging can extend product applications and regional penetration.


References

  1. MarketsandMarkets. (2023). Amino acids market by type, application, and region — Global forecast to 2028.
  2. Global Industry Analysts. (2022). The global amino acids market: Trends, forecasts, and growth opportunities.
  3. U.S. Food & Drug Administration (FDA). (2022). Regulatory guidance for amino acid-based pharmaceuticals.
  4. Smith, J., & Lee, K. (2021). Raw material price dynamics in amino acid manufacturing. Chemical Economics Handbook.
  5. European Medicines Agency (EMA). (2022). Regulatory standards for amino acid pharmaceuticals.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.